Index by author

September 1, 2022; Volume 63,Issue 9

  1. Barca, Cristina

    1. Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRI
      Open Access
      Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRI
      Claudia Foray, Cristina Barca, Alexandra Winkeler, Stefan Wagner, Sven Hermann, Michael Schäfers, Oliver M. Grauer, Bastian Zinnhardt and Andreas H. Jacobs
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1386-1393; DOI: https://doi.org/10.2967/jnumed.121.263318
    2. Short-Term Colony-Stimulating Factor 1 Receptor Inhibition–Induced Repopulation After Stroke Assessed by Longitudinal <sup>18</sup>F-DPA-714 PET Imaging
      Open Access
      Short-Term Colony-Stimulating Factor 1 Receptor Inhibition–Induced Repopulation After Stroke Assessed by Longitudinal 18F-DPA-714 PET Imaging
      Cristina Barca, Amanda J. Kiliaan, Lydia Wachsmuth, Claudia Foray, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Bastian Zinnhardt and Andreas H. Jacobs
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1408-1414; DOI: https://doi.org/10.2967/jnumed.121.263004

  2. Bauersachs, Johann

    1. Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
      Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
      Johanna Diekmann, Tobias Koenig, James T. Thackeray, Thorsten Derlin, Christoph Czerner, Jonas Neuser, Tobias L. Ross, Andreas Schäfer, Jochen Tillmanns, Johann Bauersachs and Frank M. Bengel
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1415-1423; DOI: https://doi.org/10.2967/jnumed.121.263555

  3. Beck, Roswitha

    1. Substitution of <span class="sc">l</span>-Tryptophan by <strong>α</strong>-Methyl-<span class="sc">l</span>-Tryptophan in <sup>177</sup>Lu-RM2 Results in <sup>177</sup>Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability
      Open Access
      Substitution of l-Tryptophan by α-Methyl-l-Tryptophan in 177Lu-RM2 Results in 177Lu-AMTG, a High-Affinity Gastrin-Releasing Peptide Receptor Ligand with Improved In Vivo Stability
      Thomas Günther, Sandra Deiser, Veronika Felber, Roswitha Beck and Hans-Jürgen Wester
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1364-1370; DOI: https://doi.org/10.2967/jnumed.121.263323

  4. Bengel, Frank M.

    1. Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
      Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
      Johanna Diekmann, Tobias Koenig, James T. Thackeray, Thorsten Derlin, Christoph Czerner, Jonas Neuser, Tobias L. Ross, Andreas Schäfer, Jochen Tillmanns, Johann Bauersachs and Frank M. Bengel
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1415-1423; DOI: https://doi.org/10.2967/jnumed.121.263555

  5. Benson, Angela

    1. Changes in Management After <sup>18</sup>F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
      Changes in Management After 18F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
      Michael Ng, Mario Guerrieri, Lih Ming Wong, Kim Taubman, Tom Sutherland, Angela Benson, Graeme Byrne, Sam Koschel, Kelvin Yap, Michelle Starmans, Grace Ong, Craig Macleod, Marcus Foo and Michael Chao
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1343-1348; DOI: https://doi.org/10.2967/jnumed.121.263521

  6. Berthelsen, Anne Kiil

    1. Prospective Phase II Trial of Prognostication by <sup>68</sup>Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
      Prospective Phase II Trial of Prognostication by 68Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy
      Esben Andreas Carlsen, Mathias Loft, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1371-1377; DOI: https://doi.org/10.2967/jnumed.121.263177

  7. Beziere, Nicolas

    1. Antibody-Guided Molecular Imaging of Aspergillus Lung Infections in Leukemia Patients
      Johannes Schwenck, Andreas Maurer, Nicolas Beziere, Francesco Fiz, Frederic Boschetti, Susanne Geistlich, Dominik Seyfried, Matthias Gunzer, Gerald Reischl, Jöri Wehrmüller, Walter Ehrlichmann, Marius Horger, Sergios Gatidis, Genna Davies, Wichard Vogel, Christian la Fougère, Bernd Pichler and Christopher Thornton
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1450-1451; DOI: https://doi.org/10.2967/jnumed.121.263251

  8. Boellaard, Ronald

    1. The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in <sup>18</sup>F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma
      The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in 18F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma
      Julia Driessen, Gerben J.C. Zwezerijnen, Heiko Schöder, Esther E.E. Drees, Marie José Kersten, Alison J. Moskowitz, Craig H. Moskowitz, Jakoba J. Eertink, Henrica C.W. de Vet, Otto S. Hoekstra, Josée M. Zijlstra and Ronald Boellaard
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1424-1430; DOI: https://doi.org/10.2967/jnumed.121.263067
    2. Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines)
      Abhinav K. Jha, Tyler J. Bradshaw, Irène Buvat, Mathieu Hatt, Prabhat KC, Chi Liu, Nancy F. Obuchowski, Babak Saboury, Piotr J. Slomka, John J. Sunderland, Richard L. Wahl, Zitong Yu, Sven Zuehlsdorff, Arman Rahmim and Ronald Boellaard
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1288-1299; DOI: https://doi.org/10.2967/jnumed.121.263239

  9. Boschetti, Frederic

    1. Antibody-Guided Molecular Imaging of Aspergillus Lung Infections in Leukemia Patients
      Johannes Schwenck, Andreas Maurer, Nicolas Beziere, Francesco Fiz, Frederic Boschetti, Susanne Geistlich, Dominik Seyfried, Matthias Gunzer, Gerald Reischl, Jöri Wehrmüller, Walter Ehrlichmann, Marius Horger, Sergios Gatidis, Genna Davies, Wichard Vogel, Christian la Fougère, Bernd Pichler and Christopher Thornton
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1450-1451; DOI: https://doi.org/10.2967/jnumed.121.263251

  10. Bradshaw, Tyler J.

    1. Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE Guidelines)
      Abhinav K. Jha, Tyler J. Bradshaw, Irène Buvat, Mathieu Hatt, Prabhat KC, Chi Liu, Nancy F. Obuchowski, Babak Saboury, Piotr J. Slomka, John J. Sunderland, Richard L. Wahl, Zitong Yu, Sven Zuehlsdorff, Arman Rahmim and Ronald Boellaard
      Journal of Nuclear Medicine September 1, 2022, 63 (9) 1288-1299; DOI: https://doi.org/10.2967/jnumed.121.263239
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue